Table 2.

Predictive model for VTE according to Khorana et al. [25]

Patient characteristics	Risk score
Site of cancer
Very high risk (stomach, pancreas)	2
High risk (lung, lymphoma, gynecologic, bladder, testicular)	1
Prechemotherapy platelet count ≥350,000/mm3	1
Hemoglobin level less than 10 g/dl or use of red cell growth factors	1
Prechemotherapy leukocyte count >11,000/mm3	1
Body mass index ≥35 kg/m2 or more	1

High-risk score ≥3

Intermediate risk score 1–2

Low-risk score 0